Stokes Family Office’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $556K | Buy |
7,027
+560
| +9% | +$44.3K | 0.06% | 155 |
|
|
2025
Q1 | $580K | Sell |
6,467
-829
| -11% | -$74.4K | 0.07% | 145 |
|
|
2024
Q4 | $726K | Sell |
7,296
-705
| -9% | -$70.1K | 0.08% | 133 |
|
|
2024
Q3 | $909K | Sell |
8,001
-1,969
| -20% | -$224K | 0.1% | 121 |
|
|
2024
Q2 | $1.23M | Buy |
9,970
+2,230
| +29% | +$276K | 0.14% | 108 |
|
|
2024
Q1 | $1.02M | Buy |
7,740
+641
| +9% | +$84.6K | 0.13% | 117 |
|
|
2023
Q4 | $774K | Sell |
7,099
-5,960
| -46% | -$650K | 0.1% | 120 |
|
|
2023
Q3 | $1.34M | Buy |
13,059
+1,170
| +10% | +$120K | 0.16% | 109 |
|
|
2023
Q2 | $1.37M | Buy |
11,889
+3,108
| +35% | +$359K | 0.16% | 106 |
|
|
2023
Q1 | $934K | Buy |
8,781
+174
| +2% | +$18.5K | 0.12% | 122 |
|
|
2022
Q4 | $955K | Buy |
8,607
+416
| +5% | +$46.2K | 0.12% | 112 |
|
|
2022
Q3 | $705K | Sell |
8,191
-88
| -1% | -$7.57K | 0.1% | 125 |
|
|
2022
Q2 | $755K | Buy |
8,279
+567
| +7% | +$51.7K | 0.1% | 127 |
|
|
2022
Q1 | $633K | Buy |
7,712
+60
| +0.8% | +$4.93K | 0.08% | 143 |
|
|
2021
Q4 | $586K | Sell |
7,652
-93
| -1% | -$7.12K | 0.07% | 147 |
|
|
2021
Q3 | $582K | Sell |
7,745
-137
| -2% | -$10.3K | 0.08% | 134 |
|
|
2021
Q2 | $613K | Buy |
7,882
+269
| +4% | +$20.9K | 0.09% | 124 |
|
|
2021
Q1 | $560K | Sell |
7,613
-2,995
| -28% | -$220K | 0.09% | 126 |
|
|
2020
Q4 | $828K | Buy |
10,608
+1,336
| +14% | +$104K | 0.16% | 90 |
|
|
2020
Q3 | $734K | Buy |
9,272
+520
| +6% | +$41.2K | 0.17% | 86 |
|
|
2020
Q2 | $646K | Buy |
8,752
+659
| +8% | +$48.6K | 0.16% | 92 |
|
|
2020
Q1 | $594K | Buy |
8,093
+3,885
| +92% | +$285K | 0.16% | 85 |
|
|
2019
Q4 | $377K | Buy |
+4,208
| New | +$377K | 0.08% | 107 |
|